Elos Medtech Sustainability Profile
Elos Medtech, a prominent player in the medical technology industry, is headquartered in Sweden (SE) and operates extensively across Europe and North America. Founded in 1997, the company has established itself as a leader in the development and manufacturing of advanced medical devices, particularly in orthopaedics and dental applications. Elos Medtech is renowned for its innovative solutions, including precision-engineered implants and instruments that cater to the specific needs of healthcare professionals. The company’s commitment to quality and sustainability sets it apart in a competitive market, ensuring that its products meet the highest standards of safety and efficacy. With a strong market position and a reputation for excellence, Elos Medtech continues to achieve significant milestones, contributing to advancements in patient care and enhancing the overall healthcare landscape.
DitchCarbon Score
How does Elos Medtech's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Elos Medtech's score of 22 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Elos Medtech's reported carbon emissions
In 2024, Elos Medtech reported total carbon emissions of approximately 13,185,000 kg CO2e globally. This figure represents a significant increase compared to 2023, when emissions were about 8,639,000 kg CO2e. The 2023 emissions included approximately 8,600,000 kg CO2e from their operations in China. Elos Medtech has not disclosed specific data regarding Scope 1, 2, or 3 emissions, nor have they set formal reduction targets or initiatives under the Science Based Targets initiative (SBTi). The company has not reported any climate pledges or commitments to reduce emissions, indicating a potential area for future development in their sustainability strategy. The emissions data is sourced directly from Elos Medtech AB (publ) and does not cascade from any parent or related organizations. As the company continues to grow, addressing its carbon footprint will be crucial for aligning with industry standards and responding to increasing environmental expectations.
How Carbon Intensive is Elos Medtech's Industry?
How Carbon Intensive is Elos Medtech's Location?
Elos Medtech's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Elos Medtech has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
